Zurich Insurance Group (ZURN) H2 2020 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2020 earnings summary
17 Nov, 2026Executive summary
BOP was $4.241bn vs. $5.302bn, down 20%, as COVID-19 impacts and higher catastrophe losses outweighed stronger underlying performance; results returned to growth in H2.
Net income attributable to shareholders was $3.834bn vs. $4.147bn, down 8%; lower BOP was partly offset by higher realized capital gains.
Financial highlights
Total revenues were $59.0bn vs. $71.8bn; gross written premiums and policy fees were $50.555bn vs. $50.525bn, while net written premiums and policy fees were $40.567bn vs. $41.251bn.
Total COVID-19 impact was $852m, including $450m in P&C; catastrophe losses were $588m higher YoY.
Net investment result was $6.950bn vs. $7.391bn; unit-linked investment result was $7.389bn vs. $19.485bn.
Operating cash flow was $5.701bn vs. $4.884bn; shareholders’ equity rose $3.3bn to $38.278bn, partly offset by the $3.1bn dividend payment.
Outlook and guidance
Commercial pricing trends and improved portfolio quality positioned P&C to benefit further from continuing rate increases in 2021.
Target SST ratio was reset to 160% or above; estimated year-end solvency was 182%.
Proposed dividend was stable at CHF 20 per share.
IFRS 17 and IFRS 9 are scheduled to take effect January 1, 2023; IFRS 17 was expected to significantly affect insurance accounting and presentation, with financial impact unquantified.
IFRS implementation included an initial parallel run in 2020, with work continuing into 2021 and greater focus on stakeholder education and wider operational impacts.
Latest events from Zurich Insurance Group
- Beazley scales Specialty as targets, synergies and AI productivity advance.ZURN
Investor Day 2026 - Higher earnings and BOP, despite a sharp swing in unit-linked investment results.ZURN
H2 2018 - P&C underwriting gains lifted H1 BOP 16%, with combined ratio improving to 95.1%.ZURN
H1 2019 - COVID-19 and volatile markets cut H1 earnings, while commercial growth and capital resilience held firm.ZURN
H1 2020 - BOP rose 16%, all three-year targets were exceeded, and a CHF 20 dividend was proposed.ZURN
H2 2019 - BOP rose 60%, while P&C’s 93.9% combined ratio marked a 20-year-plus low.ZURN
H1 2021 - Record 2021 profits, stronger underwriting and 212% SST support the 2022 outlook.ZURN
H2 2021 - Higher BOP was offset by investment-market losses and an $8.8bn IFRS 17 opening-equity reduction.ZURN
H2 2022 - Record BOP and 23.1% BOPAT ROE supported higher shareholder returns.ZURN
H2 2023